In line with this evidence, we found that the level of several soluble proinflammatory markers were increased (e.g., CRP, ferritin, IP-10, and IL-6) in the >65 years compared to <65 years COVID-19 patients. The gene discussed is CXCL10; the disease is COVID-19.